Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study.
about
Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE studyHormonal contraception and risk of cancer.An overview of hereditary breast and ovarian cancer syndrome.Clinical Considerations of BRCA1- and BRCA2-Mutation Carriers: A Review.
P2860
Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Oral contraceptives and postme ...... noncarriers: the WECARE Study.
@ast
Oral contraceptives and postme ...... noncarriers: the WECARE Study.
@en
type
label
Oral contraceptives and postme ...... noncarriers: the WECARE Study.
@ast
Oral contraceptives and postme ...... noncarriers: the WECARE Study.
@en
prefLabel
Oral contraceptives and postme ...... noncarriers: the WECARE Study.
@ast
Oral contraceptives and postme ...... noncarriers: the WECARE Study.
@en
P2093
P2860
P50
P1476
Oral contraceptives and postme ...... noncarriers: the WECARE Study.
@en
P2093
Bryan Langholz
Charles F Lynch
Jane C Figueiredo
Joan Largent
Jonine L Bernstein
Kathleen E Malone
Robert W Haile
Shanyan Xue
P2860
P2888
P304
P356
10.1007/S10549-009-0455-5
P407
P577
2009-07-14T00:00:00Z
P5875
P6179
1008666364